CBD basics
Does CBD show up on a drug test?
Written by: Author pendingReviewed by: Reviewer pendingUpdated:
Standard workplace panels test for THC metabolites, not CBD. Federal guidelines set the urine screen at 50 ng/mL and confirmation at 15 ng/mL of THC-COOH (HHS Mandatory Guidelines). Pure CBD does not trigger that test, but full-spectrum products carry trace THC, and repeated use can push THC metabolites over the cutoff.
The short version: the test is not looking for CBD. It is looking for what the body makes from THC. Whether a CBD product causes a problem depends almost entirely on how much THC rode along with it, and how often it was taken.
What does a drug test actually measure?
Federal workplace programs follow the HHS Mandatory Guidelines. The urine panel screens for marijuana metabolites with an immunoassay cutoff of 50 ng/mL, then confirms with mass spectrometry for THCA (11-nor-9-carboxy-THC, often written THC-COOH) at 15 ng/mL. Those guidelines took effect October 1, 2017 and anchor most private-employer panels as well.
CBD is not on that list. Its metabolites are chemically distinct, and the antibodies in a THC immunoassay are built around the THC-COOH structure. A 2022 crossover study in Drug Testing and Analysis gave 17 adults placebo or 15, 300 or 1500 mg of oral CBD and ran 515 oral-fluid tests on two roadside devices with a 10 ng/mL THC cutoff. The result was zero THC-positive results, and no THC, CBN or CBG was detected in the samples.
Why do some CBD users still fail?
Because the product was not pure CBD. Federal law allows hemp to carry delta-9 THC at up to 0.3 percent on a dry weight basis, and full-spectrum extracts keep that THC. The body turns it into THC-COOH the same way it would from any cannabis.
The clearest data come from a Johns Hopkins study published in the Journal of Analytical Toxicology. Six adults took 100 mg of pure CBD orally, 100 mg vaporized, and vaporized CBD-dominant cannabis containing 3.7 mg of THC per dose. After the pure CBD conditions, no specimen exceeded the 15 ng/mL confirmatory cutoff. After the CBD-dominant cannabis, 2 specimens screened positive at 50 ng/mL and 4 confirmed at 15 ng/mL. The authors concluded that under current federal guidelines "acute dosing of pure CBD will not result in a positive urine drug test."
That was a single dose of 3.7 mg THC. A daily full-spectrum user takes smaller amounts of THC but takes them every day, and THC-COOH accumulates in fat tissue. A systematic review of CBD pharmacokinetics reports a half-life of 2 to 5 days after chronic oral dosing; THC and its metabolites follow a similar pattern of building up with repeated use. Daily full-spectrum use for weeks is a different exposure than a single serving.
Which products carry the least risk on a test?
Isolate and broad-spectrum products with a THC result of ND (not detected) on a current certificate of analysis. Check two things on that COA: the delta-9 THC line reads ND, and the lab lists its limit of quantitation for THC, so ND means something specific rather than "did not look very hard."
Full-spectrum products are the risk category. The label may say "less than 0.3 percent THC," which is a legal statement about the hemp, not a promise about what the test will find. Under the amended federal definition that takes full effect December 11, 2026, a final product cannot contain more than 0.4 mg of total THC per innermost container, which will shrink the THC in compliant full-spectrum products but not eliminate it.
What should someone subject to testing do?
Regard it as a THC question. Anyone tested for employment, probation, athletics or the military should assume full-spectrum products can produce a positive result and should show the testing program the product's COA before using it, not after. Isolate with ND THC at a stated limit of quantitation is the conservative choice, and keeping the COA on file is the paper trail that matters if a result is disputed.
This page is general information, not personalized guidance.
General information, not personalized guidance.
Sources
- Mandatory Guidelines for Federal Workplace Drug Testing Programs (82 FR 7920) Federal Register, via GovInfo (accessed 2026-10-13)
- Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis Journal of Analytical Toxicology (accessed 2026-10-13)
- Orally administered cannabidiol does not produce false-positive tests for delta-9-THC on the Securetec DrugWipe 5S or Drager DrugTest 5000 Drug Testing and Analysis, via PubMed (accessed 2026-10-13)
- 7 U.S. Code 1639o - Definitions Cornell Law School, Legal Information Institute (accessed 2026-10-13)
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans Frontiers in Pharmacology, via PubMed Central (accessed 2026-10-13)
Related questions
Full-spectrum vs broad-spectrum vs isolate: what is the difference?
Full-spectrum hemp extract keeps the plant's cannabinoids and terpenes, including delta-9 THC up to the 0.3 percent dry-weight federal ceiling in 7 U.S.C. 1639o. Broad-spectrum...
How long does CBD stay in your system?
It depends on how often it is taken. A systematic review found single oral doses cleared with half-lives of about 1 to 2 hours in blood, while chronic oral dosing produced...
What does ND mean on a COA, and what is LOQ?
ND means "not detected" above the lab's limit of quantitation (LOQ), the smallest amount the method can measure reliably. It is not zero. With a 0.01 percent LOQ, a 30 mL bottle...
What is total THC and why does THCa count?
Total THC is delta-9 THC plus the delta-9 that THCa becomes when heated. USDA's hemp rule writes it as Total THC = (0.877 x THCA) + THC (7 CFR 990.1). From December 11, 2026, the...